Amarin Corp ADRAMRN
Price$13.00

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $186.2M-18.5% YoYTTM through 30 Jun 2026
Net Income -$27.1MTTM through 30 Jun 2026
Free Cash Flow $9.3MTTM through 30 Jun 2026

Margins

Current
Gross Margin56.6%
EBITDA Margin-21.9%
Operating Margin-23.5%
Net Margin-14.6%

Returns

-8.4%ROE
-6.1%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio3.34x
Net Debt-$302.6Mnet cash position
Cash & Equivalents$143.6M

Quality Metrics

Altman Z-Score-1.99
Piotroski F-Score6 / 9
FCF Margin5.0%
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $213.6M
Diluted EPS-$0.06TTM
'19'20'21'22'23'24'25
FY2025: $-0.09

Dividend

No dividend

Capital Allocation

R&D Spend$19M
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.